Cantor Fitzgerald analyst, Steven Halper, reiterated an Overweight rating and $80.00 price target on CVS Health (NYSE: CVS) following Centene's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE